TY - JOUR
T1 - SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder
AU - Del Dotto, Valentina
AU - Ullah, Farid
AU - Di Meo, Ivano
AU - Magini, Pamela
AU - Gusic, Mirjana
AU - Maresca, Alessandra
AU - Caporali, Leonardo
AU - Palombo, Flavia
AU - Tagliavini, Francesca
AU - Baugh, Evan Harris
AU - MacAo, Bertil
AU - Szilagyi, Zsolt
AU - Peron, Camille
AU - Gustafson, Margaret A.
AU - Khan, Kamal
AU - La Morgia, Chiara
AU - Barboni, Piero
AU - Carbonelli, Michele
AU - Valentino, Maria Lucia
AU - Liguori, Rocco
AU - Shashi, Vandana
AU - Sullivan, Jennifer
AU - Nagaraj, Shashi
AU - El-Dairi, Mays
AU - Iannaccone, Alessandro
AU - Cutcutache, Ioana
AU - Bertini, Enrico
AU - Carrozzo, Rosalba
AU - Emma, Francesco
AU - Diomedi-Camassei, Francesca
AU - Zanna, Claudia
AU - Armstrong, Martin
AU - Page, Matthew
AU - Stong, Nicholas
AU - Boesch, Sylvia
AU - Kopajtich, Robert
AU - Wortmann, Saskia
AU - Sperl, Wolfgang
AU - Davis, Erica E.
AU - Copeland, William C.
AU - Seri, Marco
AU - Falkenberg, Maria
AU - Prokisch, Holger
AU - Katsanis, Elias Nicholas
AU - Tiranti, Valeria
AU - Pippucci, Tommaso
AU - Carelli, Valerio
N1 - Funding Information:
This study was supported by Ricerca Corrente funding (AM, LC, FT, FP, MC, and VC) and by grant GR-2016-02361449 to LC, both from the Italian Ministry of Health; by the German BMBF and Horizon2020 through E-Rare project GENOMIT (01GM1603 to HP and FWF-I 2741-B26) and the German Network for Mitochondrial Disorders (mitoNET 01GM1906B to HP); and by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ES065078 to WCC and MAG). Financial support from the Mariani Foundation, Milan, and of Mitocon, Italy (grant no. 2018-01 to VT) are acknowledged. CP is supported by a fellowship from Associazione Luigi Comini Onlus, Italy. FU and KK were funded by an International Research Support Initiative Program fellowship from the Higher Education Commission of Pakistan. We thank T. Khan for technical assistance with zebrafish experiments. Family 2 was evaluated through the Duke Genome Sequencing Clinic, supported by the Duke University Health System, and partially funded by UCB Celltech. We thank Federico Sadun for referring patients from family 1 and Rosanna Carroccia for technical help with the kidney biopsy of PT1.
Publisher Copyright:
© 2020 American Society for Clinical Investigation.
PY - 2020/1/2
Y1 - 2020/1/2
N2 - optic neuropathies include complex phenotypes, mostly driven by mitochondrial dysfunction. We report an optic atrophy spectrum disorder, including retinal macular dystrophy and kidney insufficiency leading to transplantation, associated with mitochondrial DNA (mtDNA) depletion without accumulation of multiple deletions. By whole-exome sequencing, we identified mutations affecting the mitochondrial single-strand binding protein (SSBP1) in 4 families with dominant and 1 with recessive inheritance. We show that SSBP1 mutations in patient-derived fibroblasts variably affect the amount of SSBP1 protein and alter multimer formation, but not the binding to ssDNA. SSBP1 mutations impaired mtDNA, nucleoids, and 7S-DNA amounts as well as mtDNA replication, affecting replisome machinery. The variable mtDNA depletion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficiency, OXPHOS subunits, and complex amount and assembly. mtDNA depletion and cytochrome c oxidase-negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeletal muscle. Reduced efficiency of mtDNA replication was also reproduced in vitro, confirming the pathogenic mechanism. Furthermore, ssbp1 suppression in zebrafish induced signs of nephropathy and reduced optic nerve size, the latter phenotype complemented by WT mRNA but not by SSBP1 mutant transcripts. This previously unrecognized disease of mtDNA maintenance implicates SSBP1 mutations as a cause of human pathology.
AB - optic neuropathies include complex phenotypes, mostly driven by mitochondrial dysfunction. We report an optic atrophy spectrum disorder, including retinal macular dystrophy and kidney insufficiency leading to transplantation, associated with mitochondrial DNA (mtDNA) depletion without accumulation of multiple deletions. By whole-exome sequencing, we identified mutations affecting the mitochondrial single-strand binding protein (SSBP1) in 4 families with dominant and 1 with recessive inheritance. We show that SSBP1 mutations in patient-derived fibroblasts variably affect the amount of SSBP1 protein and alter multimer formation, but not the binding to ssDNA. SSBP1 mutations impaired mtDNA, nucleoids, and 7S-DNA amounts as well as mtDNA replication, affecting replisome machinery. The variable mtDNA depletion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficiency, OXPHOS subunits, and complex amount and assembly. mtDNA depletion and cytochrome c oxidase-negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeletal muscle. Reduced efficiency of mtDNA replication was also reproduced in vitro, confirming the pathogenic mechanism. Furthermore, ssbp1 suppression in zebrafish induced signs of nephropathy and reduced optic nerve size, the latter phenotype complemented by WT mRNA but not by SSBP1 mutant transcripts. This previously unrecognized disease of mtDNA maintenance implicates SSBP1 mutations as a cause of human pathology.
UR - http://www.scopus.com/inward/record.url?scp=85077402068&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077402068&partnerID=8YFLogxK
U2 - 10.1172/JCI128514
DO - 10.1172/JCI128514
M3 - Article
C2 - 31550240
AN - SCOPUS:85077402068
SN - 0021-9738
VL - 130
SP - 108
EP - 125
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 1
ER -